0.7223

7.12% -0.0554

After Hours: .78 0.0577 +7.99%

Talphera Inc (TLPH)

Overview News Price History Discussions Forecast

Talphera Inc stock is traded at $0.7223, with a volume of 172.85K. It is down -7.12% in the last 24 hours and down -20.78% over the past month. Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Previous Close:

$0.7777

Open:

$0.743

24h Volume:

172.85K

Relative Volume:

0.69

Market Cap:

$36.15M

Revenue:

$28,000

Net Income/Loss:

$-14.36M

P/E Ratio:

-1.9898

EPS:

-0.363

Net Cash Flow:

$-11.36M

1W Performance:

-6.51%

1M Performance:

-20.78%

6M Performance:

-23.26%

1Y Performance:

+23.89%

1-Day Range:

$0.711

$0.7704

1-Week Range:

$0.711

$0.7999

52-Week Range:

$0.38

$1.57

Talphera Inc Stock (TLPH) Company Profile

Name

Talphera Inc

Sector

Healthcare (1118)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

650-216-3500

Address

1850 GATEWAY DRIVE, SAN MATEO

Employee

Twitter

Next Earnings Date

2026-03-30

Latest SEC Filings

TLPH's Discussions on Twitter

Compare TLPH vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TLPH Talphera Inc	0.7223	36.15M	28,000	-14.36M	-11.36M	-0.363
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90

Talphera Inc Stock (TLPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-28-25	Initiated	Rodman & Renshaw	Buy
Jul-20-20	Downgrade	Credit Suisse	Neutral → Underperform
Nov-11-19	Downgrade	Credit Suisse	Outperform → Neutral
Aug-05-19	Resumed	Credit Suisse	Outperform
Jul-10-19	Resumed	Credit Suisse	Outperform
Apr-24-19	Resumed	B. Riley FBR	Buy
Feb-15-19	Initiated	Credit Suisse	Outperform
Oct-23-18	Initiated	B. Riley FBR	Buy
Oct-13-17	Downgrade	Jefferies	Buy → Hold
Oct-13-17	Reiterated	RBC Capital Mkts	Outperform
Jul-14-17	Resumed	Jefferies	Buy
Sep-15-16	Reiterated	ROTH Capital	Buy
Aug-05-16	Downgrade	Stifel	Buy → Hold
Oct-30-15	Upgrade	Jefferies	Hold → Buy
Oct-05-15	Reiterated	ROTH Capital	Buy
Sep-02-15	Initiated	H.C. Wainwright	Buy
Jul-10-15	Resumed	ROTH Capital	Buy
May-06-15	Reiterated	Mizuho	Neutral
May-05-15	Reiterated	RBC Capital Mkts	Outperform
Mar-10-15	Reiterated	RBC Capital Mkts	Outperform
Mar-09-15	Downgrade	Mizuho	Buy → Neutral

View All

Talphera Inc Stock (TLPH) Latest News

01:37 AM

Risk Recap: Will Talphera Inc stock hit new highs in YEAR - baoquankhu1.vn

01:37 AM

Apr 03, 2026

TALPHERA (TLPH) CEO uses 9,938 shares to cover RSU tax withholding - Stock Titan

Apr 03, 2026

Trend Recap: Does Talphera Inc stock reflect fundamentalsMarket Growth Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn

Apr 01, 2026

Talphera (NASDAQ: TLPH) registers resale of 639,931 shares and 6.4M warrant shares - Stock Titan

Apr 01, 2026

Will Talphera Inc benefit from current market trends2026 Closing Moves & Daily Oversold Bounce Ideas - baoquankhu1.vn

Apr 01, 2026

Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3 - 富途牛牛

Apr 01, 2026

Mar 30, 2026

Rate Cut: Why is Talphera Inc stock going down2026 Institutional Moves & Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

TLPH Should I Buy - Intellectia AI

Mar 29, 2026

Mar 26, 2026

Fed Meeting: Is Talphera Inc stock overvalued or fairly pricedQuarterly Portfolio Summary & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 26, 2026

Dow Update: Whats the profit margin of Talphera IncGlobal Markets & Technical Pattern Based Buy Signals - baoquankhu1.vn

Mar 26, 2026

Talphera files prospectus for resale of up to 30.9M shares by selling stockholders - MSN

Mar 26, 2026

Aug EndMonth: Is Talphera Inc a top pick in the sectorMarket Sentiment Review & Verified Short-Term Trading Plans - baoquankhu1.vn

Mar 26, 2026

Mar 25, 2026

Angotti buys Talphera (TLPH) shares worth $124,999 By Investing.com - Investing.com Australia

Mar 25, 2026

Angotti buys Talphera (TLPH) shares worth $124,999 - Investing.com

Mar 25, 2026

Talphera (TLPH) CEO boosts stake with 213,310-share open-market buy - Stock Titan

Mar 25, 2026

Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026 - Bitget

Mar 25, 2026

Mar 24, 2026

Talphera (TLPH) registers resale of up to 7.04M shares from private placement - stocktitan.net

Mar 24, 2026

Talphera (TLPH) Reports Progress in Nafamostat Study and Financi - GuruFocus

Mar 24, 2026

Talphera: Q4 Earnings Snapshot - theheraldreview.com

Mar 24, 2026

Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals - Minichart

Mar 24, 2026

Mar 23, 2026

Talphera Q4 2025 & Investor Day Earnings Call Transcript - MarketBeat

Mar 23, 2026

Talphera Inc. Q4 & Fiscal 2025 Financial Results: Revenue & Net Loss ReportNews and Statistics - IndexBox

Mar 23, 2026

[10-K] TALPHERA, INC. Files Annual Report - Stock Titan

Mar 23, 2026

Talphera 2025 10-K: Revenue $0.028M, Net Loss $14.3M - tradingview.com

Mar 23, 2026

TLPH: Net loss increased to $14.3M in 2025; urgent capital needs and Nasdaq delisting risk persist - TradingView

Mar 23, 2026